Co-Authors
This is a "connection" page, showing publications co-authored by ROBERT F GAGEL and ADEL K EL-NAGGAR.
Connection Strength
0.435
-
A miRNA signature associated with human metastatic medullary thyroid carcinoma. Endocr Relat Cancer. 2013 Dec; 20(6):809-23.
Score: 0.116
-
High resolution array-comparative genomic hybridization profiling reveals deoxyribonucleic acid copy number alterations associated with medullary thyroid carcinoma. J Clin Endocrinol Metab. 2008 Nov; 93(11):4367-72.
Score: 0.081
-
Primary hyperparathyroidism and osteosarcoma: examination of a large cohort identifies three cases of fibroblastic osteosarcoma. J Bone Miner Res. 2005 Sep; 20(9):1562-8.
Score: 0.064
-
Pheochromocytoma and medullary thyroid carcinoma: a new genotype-phenotype correlation of the RET protooncogene 891 germline mutation. J Clin Endocrinol Metab. 2004 Aug; 89(8):4142-5.
Score: 0.061
-
Phase I trial of a combination of the multikinase inhibitor sorafenib and the farnesyltransferase inhibitor tipifarnib in advanced malignancies. Clin Cancer Res. 2009 Nov 15; 15(22):7061-8.
Score: 0.022
-
Four patients with cutaneous metastases from medullary thyroid cancer. Thyroid. 2008 Aug; 18(8):901-5.
Score: 0.020
-
Medullary thyroid cancer: targeting the RET kinase pathway with sorafenib/tipifarnib. Mol Cancer Ther. 2008 May; 7(5):1001-6.
Score: 0.020
-
Parathyroid carcinoma: a 22-year experience. Head Neck. 2004 Aug; 26(8):716-26.
Score: 0.015
-
A novel point mutation of the RET protooncogene involving the second intracellular tyrosine kinase domain in a family with medullary thyroid carcinoma. J Clin Endocrinol Metab. 2004 Jul; 89(7):3521-6.
Score: 0.015
-
Limitations of size as a criterion in the evaluation of adrenal tumors. Surgery. 2000 Dec; 128(6):973-82;discussion 982-3.
Score: 0.012
-
Surgical management, DNA content, and patient survival in adrenal cortical carcinoma. Surgery. 1995 Dec; 118(6):1090-8.
Score: 0.008